血标本中的肿瘤靶点检测

Tumor biomarkers detection in blood samples

随着肿瘤个体化治疗的发展,基于分子靶点精确检测的相关靶向治疗显得愈发重要。分子靶点检测的理想标本往往来自患者肿瘤组织,然而,检测血标本中的肿瘤标志,因取材简易,方法便捷、灵活等更具优势。相信随着筛选手段和技术的不断发展,检测血标本中的肿瘤标志方法一定能更好地被应用于临床。

With the development of personalized medicine in cancer, targeted therapy based on precise detection of tumor biomarkers becomes more and more important. Tumor biomarkers detection in blood shows advantages in sample collection and flexibility of detecting methods, compared to tests using tumor biomarkers. And detection in blood samples could be applied in clinical practice better with the development of screening techniques and strategies.